glp 1 and osteoarthritis GLP-1 drugs shown cost-effective for knee obesity Do GLP-1 medicines help with

Both Eli Lilly and Novo Nordisk assert that widespread compounding poses safety concerns and undermines their intellectual property rights

These drugs treat chronic conditions requiring ongoing management, though individual circumstances and consultation with your healthcare provider should guide discontinuation decisions

Other recent studies have shown the drugs help people with obesity lower their high blood pressure and reduce their odds of heart attacks or strokes

However, its potential to prevent autoimmune diabetes remains unexplored

Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, Tie J, Hu D (2022) Regulation of SIRT1 and its roles in inflammation

Combining GLP-1 treatment with balanced nutrition, regular exercise, and behavioral changes remains essential for sustainable long-term results